Gene Therapy Oversight: Lessons for Nanobiotechnology
Authors:
- 1 January 2009
- journal article
- review article
- Published by Cambridge University Press (CUP) in Journal of Law, Medicine & Ethics
- Vol. 37 (4) , 659-684
Abstract
Nanotechnology is the “next small thing” in technological innovation. Spanning a range of science and engineering disciplines, nanotechnology will dramatically alter products and processes upon which we currently rely and promises significant advances in technology. Federal agencies taking part in the National Nanotechnology Initiative (NNI) have attempted to articulate a suitable definition for nanotechnology. The NNI definition refers to “[r]esearch and technology development at the atomic scale, molecular or macromolecular levels, in the length scale of approximately 1-100 nanometer range[; creating] and using of structures, devices and systems that have novel properties and functions because of their small size and/or intermediate size[; and the ability] to control or manipulate at the atomic scale.” Nanotechnology thus refers to material engineered or altered at the nanoscale, in order to take advantage of unique properties that emerge at that scale.Keywords
This publication has 56 references indexed in Scilit:
- Synthetic biology: promises and challengesMolecular Systems Biology, 2007
- Nano‐enabled synthetic biologyMolecular Systems Biology, 2007
- Nanotechnology: assessing the risksNano Today, 2006
- Translocation of Inhaled Ultrafine Particles to the BrainInhalation Toxicology, 2004
- Regulatory Issues for Clinical Gene Therapy TrialsHuman Gene Therapy, 2002
- US gene therapy in crisisTrends in Genetics, 2000
- Human Gene Therapy and CongressHuman Gene Therapy, 1990
- Extract from SPX no. 334: 25 August 1981COSPAR Information Bulletin, 1981
- Comparison of Ontogeny of Three Types of Leaf Architecture in Sorbus L. (Rosaceae)Botanical Gazette, 1979
- Guidelines for DNA Hybrid MoleculesScience, 1973